Home > Insider Trading > Filing (0001209784-16-000059)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1116463	Orasure Technologies Inc	OSUR	Surgical & Medical Instruments & Apparatus (3841)	364370966

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1295391	A Douglas Michels	220 East First Street Bethlehem PA 18015	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-12-13	15,216	$8.28	747,114	No	4	M	Direct
Common Stock	Acquisiton	2016-12-13	56,250	$8.06	803,364	No	4	M	Direct
Common Stock	Disposition	2016-12-13	15,216	$9.02	788,148	No	4	S	Direct
Common Stock	Disposition	2016-12-13	56,250	$9.08	731,898	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-qualified stock options	Disposition	2016-12-13	15,216	$0.00	15,216	$8.28
Common Stock	Non-qualified stock options	Disposition	2016-12-13	56,250	$0.00	56,250	$8.06

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2017-02-01	No	4	M	Direct
0		2018-02-01	No	4	M	Direct

Footnotes

Sale pursuant to a predetermined sales plan, entered into on August 22, 2016 under Rule 10b5-1 of the Securities and Exchange Act of 1934.
Nonqualified stock options granted on February 1, 2007 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.
Nonqualified stock options granted on February 1, 2008 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.